No Clinically Significant Interaction Between Crestor and THC
There is no documented or clinically significant drug interaction between rosuvastatin (Crestor) and THC soft-gel capsules based on available evidence. You can safely prescribe or continue both medications together without dose adjustments.
Why This Combination Is Safe
Rosuvastatin's Unique Metabolic Profile
Rosuvastatin has minimal metabolism through the cytochrome P450 system—only about 10% of the drug undergoes hepatic metabolism, primarily via CYP2C9 1, 2. This makes rosuvastatin remarkably resistant to metabolism-based drug interactions compared to other statins like atorvastatin or simvastatin, which are heavily metabolized by CYP3A4 3.
THC Metabolism Doesn't Overlap
THC is primarily metabolized through CYP2C9 and CYP3A4. While there is theoretical overlap at CYP2C9, rosuvastatin's minimal dependence on this pathway means any competitive inhibition would be clinically insignificant 4, 5.
Rosuvastatin's Primary Elimination Pathways
Rosuvastatin is eliminated primarily unchanged through:
- Hepatic uptake via OATP1B1/3 transporters
- Direct biliary and renal excretion
- Not significantly dependent on CYP450 metabolism 3, 4
THC does not interact with these transporter systems in any documented manner.
Evidence Supporting Safety
The comprehensive 2016 American Heart Association guidelines on statin drug interactions 3 make no mention of cannabis or cannabinoids as interacting agents, despite exhaustively covering medications metabolized through overlapping pathways. This guideline specifically addresses agents that interact with rosuvastatin through CYP450 or transporter mechanisms—THC is notably absent.
Recent research on CBD (a related cannabinoid) in cancer patients taking multiple medications found no clinically significant drug interactions even in the context of polypharmacy 6. While this study focused on CBD rather than THC, it demonstrates that cannabinoids do not produce widespread metabolic interference.
Documented Rosuvastatin Interactions to Actually Worry About
The FDA label 1 and guidelines 3 identify these true interactions requiring dose adjustments:
- Cyclosporine: Limit rosuvastatin to 5 mg daily
- Gemfibrozil: Avoid combination; if necessary, limit rosuvastatin to 10 mg daily
- Lopinavir/ritonavir: Limit rosuvastatin to 10 mg daily
- Warfarin: Monitor INR closely
THC is not among these agents.
Clinical Pitfalls to Avoid
Don't confuse rosuvastatin with simvastatin or atorvastatin. Those statins ARE heavily metabolized by CYP3A4 and have numerous documented drug interactions 3. Rosuvastatin's pharmacokinetic profile is fundamentally different and safer regarding drug interactions 4, 2.
The only documented interaction affecting rosuvastatin absorption involves aluminum/magnesium antacids taken simultaneously, which reduce rosuvastatin levels by 50% 1, 7. This is irrelevant to THC.
Practical Recommendation
Continue both medications without modification. No dose adjustment, no additional monitoring beyond standard statin management (baseline and periodic lipid panels, liver function tests). The theoretical concern about CYP2C9 overlap has no clinical significance given rosuvastatin's minimal metabolism 5, 2.